BMRN - Latest News
BioMarin Pharmaceutical Inc. (BMRN), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $13.02B. Trailing twelve-month P/E ratio is 178.12. Beta to the broader market is 0.23.
The article list below shows the most recent BMRN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BMRN Headlines
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?
zacks.com - Aug 14, 2026
Here is how BioMarin Pharmaceutical (BMRN) and Cardinal Health (CAH) have performed compared to their sector so far this year.
5 Undervalued Price-to-Book Stocks Worth Buying in August
zacks.com - Aug 13, 2026
BioMarin, Invesco, Centene, HPE and Gibraltar Industries stand out as undervalued stocks with low price-to-book ratios.
BMRN vs. ILMN: Which Stock Is the Better Value Option?
zacks.com - Aug 12, 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Illumina
Wall Street Analysts See a 28.2% Upside in BioMarin (BMRN): Can the Stock Really Move This High?
zacks.com - Aug 12, 2026
The mean of analysts' price targets for BioMarin (BMRN) points to a 28. 2% upside in the stock.
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
zacks.com - Aug 12, 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
How News Affects BMRN Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BMRN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BMRN news questions
- What is the latest BMRN news headline?
- The most recent BMRN headline (Aug 14, 2026) is "Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BMRN news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BMRN news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BMRN options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.